High and rising prescription drug prices force consumers to skip doses or even avoid filling their prescriptions for life-saving medications altogether. Now is the perfect time for Congress to finally begin to take action by including the bipartisan CREATES Act in the omnibus legislation to fund the government, which must pass Congress by March 23rd.
We know how the House Republican bill could affect people who get insurance through the Affordable Care Act (ACA) marketplace and Medicaid. But what has been overlooked is how the bill, known as the American Health Care Act (AHCA), could affect the coverage people get through their jobs. In other words: The Republican bill could make everybody’s coverage worse.
Through our new Community Health Worker Sustainability Collaborative, launched with the support of the Kresge Foundation, we will work with CHW organizations, health care and health equity advocates, policy makers, and other stakeholders to promote using Medicaid funds to provide more sustainable support to CHW programs and better integrate them into the health care system.
We know that unleashing the power of CHWs in communities across the country will make a tremendous difference in health and health care, especially in communities of color.
Nothing about high-deductible plans makes health care more affordable for families. While the Republicans have yet to agree on how they propose to replace the Affordable Care Act (ACA), one thing is clear—whatever they pursue will push more families into high-deductible plans. Every single replacement plan put forth so far would very likely increase deductibles for millions of people.
The Medicare Access and CHIP Reauthorization Act (MACRA) is the biggest change to how Medicare pays for services in decades. It will accelerate the movement towards value-based payments—where what health care providers get paid depends, at least partially, on the quality of care they provide, not just the volume of services. On June 27, Families USA submitted comments about how the law will be implemented.
As drug prices continue to rise at an unsustainable rate, we must ensure that our health care system and its financial incentives enhance the quality and value of care. We believe the Medicare Part B prescription drug model proposed by the Centers for Medicare & Medicaid Services (CMS) creates value for the patient and the program by encouraging treatment choices that have been shown to improve care and health outcomes.
Last Wednesday, the Centers for Medicare & Medicaid Services (CMS) released a proposed rule to implement key provisions of the Medicare Access & CHIP Reauthorization Act. Passed with bipartisan support in 2015, MACRA represents is an important opportunity to improve the quality of care delivered through Medicare. Given the number of people who are enrolled in Medicare and the number of providers who see Medicare patients, these changes will have a significant impact throughout the entire health care system.
Recent actions by the Center for Medicare and Medicaid Services (CMS) represent an encouraging recognition–by one of the biggest payers of health care in the nation—that one-size-fits all payment reforms do not benefit everyone equally.
And they raise the question of whether some of these pay-for-performance programs should be adjusted to better address racial and ethnic health disparities.
By now the benefits of Medicaid expansion are well known. In addition to providing health coverage to millions of Americans, it has helped create new health care jobs, decrease hospitals’ spending on uncompensated care, and generate budget savings for states. But another benefit is often overlooked: Medicaid expansion can help improve the quality of health care and reduce costs throughout a state’s entire health care system, not just in Medicaid.